Patent Assignment
Reel/Frame 054522/0207
Assignment of Assignor's Interest
Recorded: 2020-12-02
Pages: 6
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Targeting Lipids
Application:
15/729,236 →
Publication:
US 2019/0099493
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →
Assignment of Assignor's Interest
Dec 2, 2020
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; NAIR, JAYAPRAKASH K.; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 054522/0066 →
Change of Name
Dec 2, 2020
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 054522/0274 →